Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.

Tumor Necrosis Factor (TNF)-α, is a paracrine inhibitor of melanocytes, which plays a critical role in the pathogenesis of several autoimmune diseases including vitiligo, as abnormal immune responses have frequently been observed in vitiligo patients. Moreover, vitiligo patients show higher lesion l...

Full description

Bibliographic Details
Main Authors: Naresh C Laddha, Mitesh Dwivedi, Rasheedunnisa Begum
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-12-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284977/?tool=EBI
_version_ 1818701564788867072
author Naresh C Laddha
Mitesh Dwivedi
Rasheedunnisa Begum
author_facet Naresh C Laddha
Mitesh Dwivedi
Rasheedunnisa Begum
author_sort Naresh C Laddha
collection DOAJ
description Tumor Necrosis Factor (TNF)-α, is a paracrine inhibitor of melanocytes, which plays a critical role in the pathogenesis of several autoimmune diseases including vitiligo, as abnormal immune responses have frequently been observed in vitiligo patients. Moreover, vitiligo patients show higher lesion levels of TNF-α. Genetic polymorphisms in the promoter region of TNF-α are involved in the regulation of its expression. The present study explores TNF-α promoter polymorphisms and correlates them with TNF-α transcript and protein levels in vitiligo patients and controls of Gujarat along with its effect on disease onset and progression. PCR-RFLP technique was used for genotyping of these polymorphisms in 977 vitiligo patients and 990 controls. TNF-α transcript and protein levels were measured by Real time PCR and ELISA respectively. The genotype and allele frequencies for the investigated polymorphisms were significantly associated with vitiligo patients. The study revealed significant increase in TNF-α transcript and protein levels in vitiligo patients compared to controls. In particular, haplotypes: AATCC, AACCT, AGTCT, GATCT, GATCC and AGCCT were found to increase the TNF-α levels in vitiligo patients. Analysis of TNF-α levels based on the gender and disease progression suggests that female patients and patients with active vitiligo had higher levels of TNF-α. Also, the TNF-α levels were high in patients with generalized vitiligo as compared to localized vitiligo. Age of onset analysis of the disease suggests that the haplotypes: AACAT, AACCT, AATCC and AATCT had a profound effect in the early onset of the disease. Moreover, the analysis suggests that female patients had an early onset of vitiligo. Overall, our results suggest that TNF-α promoter polymorphisms may be genetic risk factors for susceptibility and progression of the disease. The up-regulation of TNF-α transcript and protein levels in individuals with susceptible haplotypes advocates the crucial role of TNF-α in autoimmune pathogenesis of vitiligo.
first_indexed 2024-12-17T15:22:51Z
format Article
id doaj.art-98aa392250fa4b2180bd4f6163378ba8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T15:22:51Z
publishDate 2012-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-98aa392250fa4b2180bd4f6163378ba82022-12-21T21:43:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-12-01712e5229810.1371/journal.pone.0052298Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.Naresh C LaddhaMitesh DwivediRasheedunnisa BegumTumor Necrosis Factor (TNF)-α, is a paracrine inhibitor of melanocytes, which plays a critical role in the pathogenesis of several autoimmune diseases including vitiligo, as abnormal immune responses have frequently been observed in vitiligo patients. Moreover, vitiligo patients show higher lesion levels of TNF-α. Genetic polymorphisms in the promoter region of TNF-α are involved in the regulation of its expression. The present study explores TNF-α promoter polymorphisms and correlates them with TNF-α transcript and protein levels in vitiligo patients and controls of Gujarat along with its effect on disease onset and progression. PCR-RFLP technique was used for genotyping of these polymorphisms in 977 vitiligo patients and 990 controls. TNF-α transcript and protein levels were measured by Real time PCR and ELISA respectively. The genotype and allele frequencies for the investigated polymorphisms were significantly associated with vitiligo patients. The study revealed significant increase in TNF-α transcript and protein levels in vitiligo patients compared to controls. In particular, haplotypes: AATCC, AACCT, AGTCT, GATCT, GATCC and AGCCT were found to increase the TNF-α levels in vitiligo patients. Analysis of TNF-α levels based on the gender and disease progression suggests that female patients and patients with active vitiligo had higher levels of TNF-α. Also, the TNF-α levels were high in patients with generalized vitiligo as compared to localized vitiligo. Age of onset analysis of the disease suggests that the haplotypes: AACAT, AACCT, AATCC and AATCT had a profound effect in the early onset of the disease. Moreover, the analysis suggests that female patients had an early onset of vitiligo. Overall, our results suggest that TNF-α promoter polymorphisms may be genetic risk factors for susceptibility and progression of the disease. The up-regulation of TNF-α transcript and protein levels in individuals with susceptible haplotypes advocates the crucial role of TNF-α in autoimmune pathogenesis of vitiligo.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284977/?tool=EBI
spellingShingle Naresh C Laddha
Mitesh Dwivedi
Rasheedunnisa Begum
Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
PLoS ONE
title Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
title_full Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
title_fullStr Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
title_full_unstemmed Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
title_short Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
title_sort increased tumor necrosis factor tnf α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284977/?tool=EBI
work_keys_str_mv AT nareshcladdha increasedtumornecrosisfactortnfaanditspromoterpolymorphismscorrelatewithdiseaseprogressionandhighersusceptibilitytowardsvitiligo
AT miteshdwivedi increasedtumornecrosisfactortnfaanditspromoterpolymorphismscorrelatewithdiseaseprogressionandhighersusceptibilitytowardsvitiligo
AT rasheedunnisabegum increasedtumornecrosisfactortnfaanditspromoterpolymorphismscorrelatewithdiseaseprogressionandhighersusceptibilitytowardsvitiligo